1. Home
  2. ARKO vs FDMT Comparison

ARKO vs FDMT Comparison

Compare ARKO & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARKO Corp.

ARKO

ARKO Corp.

HOLD

Current Price

$6.26

Market Cap

523.7M

Sector

Energy

ML Signal

HOLD

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

HOLD

Current Price

$8.60

Market Cap

513.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARKO
FDMT
Founded
1970
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
523.7M
513.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ARKO
FDMT
Price
$6.26
$8.60
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$7.50
$34.13
AVG Volume (30 Days)
571.5K
766.3K
Earning Date
01-01-0001
04-13-2026
Dividend Yield
1.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$37,000.00
Revenue This Year
$13.58
$21,227.03
Revenue Next Year
N/A
$161.87
P/E Ratio
$56.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.51
$2.24
52 Week High
$6.71
$12.34

Technical Indicators

Market Signals
Indicator
ARKO
FDMT
Relative Strength Index (RSI) 57.30 44.29
Support Level $3.94 $8.11
Resistance Level $6.71 $8.80
Average True Range (ATR) 0.27 0.57
MACD -0.03 -0.12
Stochastic Oscillator 58.23 11.49

Price Performance

Historical Comparison
ARKO
FDMT

About ARKO ARKO Corp.

ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. The company derives the majority of its revenue from retail and wholesale distribution of fuel.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: